ESR1 and prostate cancer: To investigate the underlying mechanisms of sexual dimorphism in the skeletal effects of Sirt1 haplo-insufficiency, we studied sex hormone receptors, as a cross talk between SIRT1 and ERα and AR has been previously reported in the context of breast and prostate cancer, respectively (23, 30).